Reply to Chemical Risk Factors of Primary Liver Cancer: A Short Comment [Response To Letter]

Adam Barsouk,1 Krishna Chaitanya Thandra,2 Kalyan Saginala,3 Prashanth Rawla4 1Sidney Kimmel Cancer Center, Jefferson University, Philadelphia, PA, 19107, USA; 2Department of Pulmonary and Critical Care Medicine, Sentara Virginia Beach General Hospital, Virginia Beach, VA, USA; 3Plains Regional Medi...

Full description

Saved in:
Bibliographic Details
Published in:Hepatic medicine: evidence and research 2021-01, Vol.13, p.145-146
Main Authors: Barsouk, Adam, Thandra, Krishna Chaitanya, Saginala, Kalyan, Rawla, Prashanth
Format: Article
Language:English
Subjects:
4-aminobiphenyl
4′-methylene bis (2-chlorobenzenamine)(moca)
benzidine
hepatocellular carcinoma
Liver cancer
ortho-toluidine
Response to Letter
Risk factors
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 146
container_issue
container_start_page 145
container_title Hepatic medicine: evidence and research
container_volume 13
creator Barsouk, Adam
Thandra, Krishna Chaitanya
Saginala, Kalyan
Rawla, Prashanth
description Adam Barsouk,1 Krishna Chaitanya Thandra,2 Kalyan Saginala,3 Prashanth Rawla4 1Sidney Kimmel Cancer Center, Jefferson University, Philadelphia, PA, 19107, USA; 2Department of Pulmonary and Critical Care Medicine, Sentara Virginia Beach General Hospital, Virginia Beach, VA, USA; 3Plains Regional Medical Group Internal Medicine, Clovis, NM, 88101, USA; 4Department of Medicine, Sovah Health, Martinsville, VA, 24112, USACorrespondence: Prashanth RawlaDepartment of Internal Medicine/Hospitalist, SOVAH Health, 320 Hospital Dr, Martinsville, VA, 24115, USAEmail rawlap@gmail.com View the original paper by Mr Barsouk and colleagues This is in response to the Letter to the Editor
doi_str_mv 10.2147/HMER.S352746
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_42cd0d1ebed848f5b0d08ff1d8bc60ac</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A689995255</galeid><doaj_id>oai_doaj_org_article_42cd0d1ebed848f5b0d08ff1d8bc60ac</doaj_id><sourcerecordid>A689995255</sourcerecordid><originalsourceid>FETCH-LOGICAL-c463t-b6e279d3b8c40c5f4348f76a4b45112b43782b613c5b04ef93567e4be1ed57e43</originalsourceid><addsrcrecordid>eNptkt9v0zAQxyMEYtPYG8_IEhLigRb_TsIDUhVtbFIRqBtPgCzHubQuSVxsZ9L-e1xaRouwH3w6f-57vvNl2XOCp5Tw_O3Vx4vF9IYJmnP5KDslJC8nRDDx-MA-yc5DWOO0WFmynD7NTpjAmDKWn2bfFrDp7lF0qFpBb43u0MKGH-hSm-h8QK5Fn73ttb9Hc3sHHlV6MODfoRm6WTkfUeX6HoaIvi4gbNwQAN06NIcYwX9_lj1pdRfgfH-eZV8uL26rq8n804frajafGC5ZnNQSaF42rC4Mx0a0nPGizaXmNReE0JqzvKC1JMyIGnNoSyZkDrwGAo1IBjvLrne6jdNrtdm9Vzlt1W-H80ulfbSmA8WpaXBDoIamSFmSYIOLtiVNURuJtUla73dam7HuoTGpNq-7I9Hjm8Gu1NLdqSKnVEiZBF7vBbz7OUKIqrfBQNfpAdwYFJWkEISRkib05T_o2o1-SK1KFMWYCyn4X2qpUwF2aF3Ka7aiaiaLsiwFFSJR0_9QaTfbb3UDtDb5jwJeHQSsQHdxFVw3Rpt-8Rh8swONdyF4aB-aQbDaTqHaTqHaT2HCXxw28AH-M3PsF1aU1Gg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2620045654</pqid></control><display><type>article</type><title>Reply to Chemical Risk Factors of Primary Liver Cancer: A Short Comment [Response To Letter]</title><source>Taylor &amp; Francis Open Access</source><source>Publicly Available Content Database</source><source>PubMed Central(OpenAccess)</source><creator>Barsouk, Adam ; Thandra, Krishna Chaitanya ; Saginala, Kalyan ; Rawla, Prashanth</creator><creatorcontrib>Barsouk, Adam ; Thandra, Krishna Chaitanya ; Saginala, Kalyan ; Rawla, Prashanth</creatorcontrib><description>Adam Barsouk,1 Krishna Chaitanya Thandra,2 Kalyan Saginala,3 Prashanth Rawla4 1Sidney Kimmel Cancer Center, Jefferson University, Philadelphia, PA, 19107, USA; 2Department of Pulmonary and Critical Care Medicine, Sentara Virginia Beach General Hospital, Virginia Beach, VA, USA; 3Plains Regional Medical Group Internal Medicine, Clovis, NM, 88101, USA; 4Department of Medicine, Sovah Health, Martinsville, VA, 24112, USACorrespondence: Prashanth RawlaDepartment of Internal Medicine/Hospitalist, SOVAH Health, 320 Hospital Dr, Martinsville, VA, 24115, USAEmail rawlap@gmail.com View the original paper by Mr Barsouk and colleagues This is in response to the Letter to the Editor</description><identifier>ISSN: 1179-1535</identifier><identifier>EISSN: 1179-1535</identifier><identifier>DOI: 10.2147/HMER.S352746</identifier><identifier>PMID: 35002337</identifier><language>eng</language><publisher>New Zealand: Dove Medical Press Limited</publisher><subject>4-aminobiphenyl ; 4′-methylene bis (2-chlorobenzenamine)(moca) ; benzidine ; hepatocellular carcinoma ; Liver cancer ; ortho-toluidine ; Response to Letter ; Risk factors</subject><ispartof>Hepatic medicine: evidence and research, 2021-01, Vol.13, p.145-146</ispartof><rights>COPYRIGHT 2021 Dove Medical Press Limited</rights><rights>2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 Barsouk et al. 2021 Barsouk et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0002-4361-8498</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2620045654/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2620045654?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35002337$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Barsouk, Adam</creatorcontrib><creatorcontrib>Thandra, Krishna Chaitanya</creatorcontrib><creatorcontrib>Saginala, Kalyan</creatorcontrib><creatorcontrib>Rawla, Prashanth</creatorcontrib><title>Reply to Chemical Risk Factors of Primary Liver Cancer: A Short Comment [Response To Letter]</title><title>Hepatic medicine: evidence and research</title><addtitle>Hepat Med</addtitle><description>Adam Barsouk,1 Krishna Chaitanya Thandra,2 Kalyan Saginala,3 Prashanth Rawla4 1Sidney Kimmel Cancer Center, Jefferson University, Philadelphia, PA, 19107, USA; 2Department of Pulmonary and Critical Care Medicine, Sentara Virginia Beach General Hospital, Virginia Beach, VA, USA; 3Plains Regional Medical Group Internal Medicine, Clovis, NM, 88101, USA; 4Department of Medicine, Sovah Health, Martinsville, VA, 24112, USACorrespondence: Prashanth RawlaDepartment of Internal Medicine/Hospitalist, SOVAH Health, 320 Hospital Dr, Martinsville, VA, 24115, USAEmail rawlap@gmail.com View the original paper by Mr Barsouk and colleagues This is in response to the Letter to the Editor</description><subject>4-aminobiphenyl</subject><subject>4′-methylene bis (2-chlorobenzenamine)(moca)</subject><subject>benzidine</subject><subject>hepatocellular carcinoma</subject><subject>Liver cancer</subject><subject>ortho-toluidine</subject><subject>Response to Letter</subject><subject>Risk factors</subject><issn>1179-1535</issn><issn>1179-1535</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkt9v0zAQxyMEYtPYG8_IEhLigRb_TsIDUhVtbFIRqBtPgCzHubQuSVxsZ9L-e1xaRouwH3w6f-57vvNl2XOCp5Tw_O3Vx4vF9IYJmnP5KDslJC8nRDDx-MA-yc5DWOO0WFmynD7NTpjAmDKWn2bfFrDp7lF0qFpBb43u0MKGH-hSm-h8QK5Fn73ttb9Hc3sHHlV6MODfoRm6WTkfUeX6HoaIvi4gbNwQAN06NIcYwX9_lj1pdRfgfH-eZV8uL26rq8n804frajafGC5ZnNQSaF42rC4Mx0a0nPGizaXmNReE0JqzvKC1JMyIGnNoSyZkDrwGAo1IBjvLrne6jdNrtdm9Vzlt1W-H80ulfbSmA8WpaXBDoIamSFmSYIOLtiVNURuJtUla73dam7HuoTGpNq-7I9Hjm8Gu1NLdqSKnVEiZBF7vBbz7OUKIqrfBQNfpAdwYFJWkEISRkib05T_o2o1-SK1KFMWYCyn4X2qpUwF2aF3Ka7aiaiaLsiwFFSJR0_9QaTfbb3UDtDb5jwJeHQSsQHdxFVw3Rpt-8Rh8swONdyF4aB-aQbDaTqHaTqHaT2HCXxw28AH-M3PsF1aU1Gg</recordid><startdate>20210101</startdate><enddate>20210101</enddate><creator>Barsouk, Adam</creator><creator>Thandra, Krishna Chaitanya</creator><creator>Saginala, Kalyan</creator><creator>Rawla, Prashanth</creator><general>Dove Medical Press Limited</general><general>Taylor &amp; Francis Ltd</general><general>Dove</general><general>Dove Medical Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-4361-8498</orcidid></search><sort><creationdate>20210101</creationdate><title>Reply to Chemical Risk Factors of Primary Liver Cancer: A Short Comment [Response To Letter]</title><author>Barsouk, Adam ; Thandra, Krishna Chaitanya ; Saginala, Kalyan ; Rawla, Prashanth</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c463t-b6e279d3b8c40c5f4348f76a4b45112b43782b613c5b04ef93567e4be1ed57e43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>4-aminobiphenyl</topic><topic>4′-methylene bis (2-chlorobenzenamine)(moca)</topic><topic>benzidine</topic><topic>hepatocellular carcinoma</topic><topic>Liver cancer</topic><topic>ortho-toluidine</topic><topic>Response to Letter</topic><topic>Risk factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Barsouk, Adam</creatorcontrib><creatorcontrib>Thandra, Krishna Chaitanya</creatorcontrib><creatorcontrib>Saginala, Kalyan</creatorcontrib><creatorcontrib>Rawla, Prashanth</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Research Library (ProQuest)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Hepatic medicine: evidence and research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Barsouk, Adam</au><au>Thandra, Krishna Chaitanya</au><au>Saginala, Kalyan</au><au>Rawla, Prashanth</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reply to Chemical Risk Factors of Primary Liver Cancer: A Short Comment [Response To Letter]</atitle><jtitle>Hepatic medicine: evidence and research</jtitle><addtitle>Hepat Med</addtitle><date>2021-01-01</date><risdate>2021</risdate><volume>13</volume><spage>145</spage><epage>146</epage><pages>145-146</pages><issn>1179-1535</issn><eissn>1179-1535</eissn><abstract>Adam Barsouk,1 Krishna Chaitanya Thandra,2 Kalyan Saginala,3 Prashanth Rawla4 1Sidney Kimmel Cancer Center, Jefferson University, Philadelphia, PA, 19107, USA; 2Department of Pulmonary and Critical Care Medicine, Sentara Virginia Beach General Hospital, Virginia Beach, VA, USA; 3Plains Regional Medical Group Internal Medicine, Clovis, NM, 88101, USA; 4Department of Medicine, Sovah Health, Martinsville, VA, 24112, USACorrespondence: Prashanth RawlaDepartment of Internal Medicine/Hospitalist, SOVAH Health, 320 Hospital Dr, Martinsville, VA, 24115, USAEmail rawlap@gmail.com View the original paper by Mr Barsouk and colleagues This is in response to the Letter to the Editor</abstract><cop>New Zealand</cop><pub>Dove Medical Press Limited</pub><pmid>35002337</pmid><doi>10.2147/HMER.S352746</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-4361-8498</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1179-1535
ispartof Hepatic medicine: evidence and research, 2021-01, Vol.13, p.145-146
issn 1179-1535
1179-1535
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_42cd0d1ebed848f5b0d08ff1d8bc60ac
source Taylor & Francis Open Access; Publicly Available Content Database; PubMed Central(OpenAccess)
subjects 4-aminobiphenyl
4′-methylene bis (2-chlorobenzenamine)(moca)
benzidine
hepatocellular carcinoma
Liver cancer
ortho-toluidine
Response to Letter
Risk factors
title Reply to Chemical Risk Factors of Primary Liver Cancer: A Short Comment [Response To Letter]
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T19%3A04%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reply%20to%20Chemical%20Risk%20Factors%20of%20Primary%20Liver%20Cancer:%20A%20Short%20Comment%20%5BResponse%20To%20Letter%5D&rft.jtitle=Hepatic%20medicine:%20evidence%20and%20research&rft.au=Barsouk,%20Adam&rft.date=2021-01-01&rft.volume=13&rft.spage=145&rft.epage=146&rft.pages=145-146&rft.issn=1179-1535&rft.eissn=1179-1535&rft_id=info:doi/10.2147/HMER.S352746&rft_dat=%3Cgale_doaj_%3EA689995255%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c463t-b6e279d3b8c40c5f4348f76a4b45112b43782b613c5b04ef93567e4be1ed57e43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2620045654&rft_id=info:pmid/35002337&rft_galeid=A689995255&rfr_iscdi=true